0001209191-18-052464.txt : 20180927 0001209191-18-052464.hdr.sgml : 20180927 20180927165014 ACCESSION NUMBER: 0001209191-18-052464 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180926 FILED AS OF DATE: 20180927 DATE AS OF CHANGE: 20180927 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dentzer James E CENTRAL INDEX KEY: 0001400977 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30347 FILM NUMBER: 181091527 MAIL ADDRESS: STREET 1: C/O AMICUS THERAPEUTICS, INC. STREET 2: 6 CEDAR BROOK DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CURIS INC CENTRAL INDEX KEY: 0001108205 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 043505116 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4 MAGUIRE ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 617-503-6500 MAIL ADDRESS: STREET 1: 4 MAGUIRE ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-09-26 0 0001108205 CURIS INC CRIS 0001400977 Dentzer James E C/O CURIS, INC. 4 MAGUIRE ROAD LEXINGTON MA 02421 1 1 0 0 President & CEO Employee stock option (right to buy) 1.62 2018-09-26 4 A 0 750000 0.00 A 2028-09-25 Common stock 750000 750000 D This option vests as to 25% of the shares on September 26, 2019 and as to an additional 6.25% of the original shares each successive three month period through and until September 26, 2022. William Steinkrauss, Attorney-in-fact 2018-09-27